Solicite una cita

Frank A. Sinicrope, M.D.

  1. Gastroenterologist
  2. Internist
  3. Oncologist

Departamentos

Location

  1. Rochester, Minnesota

Idiomas

English

Pacientes existentes

  1. Colon cancer
  1. Chemotherapy
  2. Immunotherapy
  • Colorectal cancer therapy including immunotherapy
  • Young onset cancer and hereditary cancer syndromes
  • Gastrointestinal cancers
  1. 2021
    MD - Leadership Development for Physicians in Academic Health Centers, Harvard UniversityHarvard University
  2. 1997
    Fellow - Medical OncologyUniversity of Texas M.D. Anderson Cancer Center
  3. 1992
    Research Fellowship - Gastroenterology, National Institutes of Health Research FellowUniversity of Chicago
  4. 1991
    Fellow - Gastroenterology/HepatologyUniversity of Chicago Hospitals
  5. 1989
    Resident - MedicineMichael Reese Hospital
  6. 1987
    Internship - MedicineMichael Reese Hospital
  7. 1985
    MDUniversity Of Chicago Pritzker School Of Medicine
  8. 1981
    AB - BiologyOccidental College

Certifications

  1. 1998
    Medical OncologyAmerican Board of Internal Medicine
  2. 1991
    GastroenterologyAmerican Board of Internal Medicine
  3. 1989
    Internal MedicineAmerican Board of Internal Medicine

Awards and honors

  1. 2000
    Visiting ProfessorSouth Carolina Cancer Center
  2. 1999
    Kadoorie Human Cancer Genetics AwardUniversity of Texas M.D. Anderson Cancer Center
  3. 1997
    Clinical Oncology Career Development AwardAmerican Cancer Society
  4. 1995
    Basic Science Research AwardGlaxo Institute for Digestive Health
  5. 1982
    Student Research AwardAmerican Heart Association
  6. 1981
    Graduated cum laudeOccidental College

Professional memberships

  1. 2022 - present
    PathAI Organization
  2. 2022 - present
    Targeted Oncology
  3. 2022 - present
    Mayo Clinic GIH Neoplasia Interest Group
  4. 2022 - present
    Eisai Pharmaceuticals Advisory Board
  5. 2021 - present
    Clinical Trials Work Group, EPIC Research Subcommittee
  6. 2021 - present
    Protagonist Therapeutics
  7. 2020 - present
    National Cancer Institute, Colon Cancer Task Force
  8. 2019 - present
    Alliance for Clinical Trials in Oncology, Immunotherapy Committee
  9. 2019 - present
    Guardant Health, Inc., Eclipse Steering Committee
  10. 2019 - 2022
    ASCO Conquer Cancer Grant Selection Committee
  11. 2019 - present
    Familial Cancer Cross Disciplinary Group
  12. 2018 - 2019
    HalioDx,-Luminy Biotech Enterprises
  13. 2018 - present
    Cancer Care Models: Colorectal Cancer - Ask Mayo Expert
  14. 2017
    GI Translational Research Committee, Mayo Clinic/North Central Cancer Treatment Group
  15. 2017 - 2020
    American Society of Clinical Oncology (ASCO) Program Committee
  16. 2017 - 2018
    Bristol Meyers Squibb
  17. 2017
    Roche Sequencing Solutions
  18. 2017
    Hoffman LaRoche/Genentech Scientific Advisory Board
  19. 2016
    EMD Serono, Scientific Advisory Board
  20. 2015 - present
    Gastrointestinal Cancer Research Program, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  21. 2014 - present
    National Cancer Institute, Gastrointestinal Cancer Steering Committee
  22. 2014 - present
    Alliance for Clinical Trials in Oncology, Prevention Committee
  23. 2013
    Bayer Pharmaceuticals
  24. 2012 - present
    Center for Cell Signaling in Gastroenterology
  25. 2012 - present
    Alliance for Clinical Trials in Oncology, Translational Research Executive Committee
  26. 2012 - present
    Alliance for Clinical Trials in Oncology, GI Committee
  27. 2012 - present
    Ventana Medical Systems
  28. 2011 - 2017
    World Gastroenterology Organization, Task Force on Digestive Oncology
  29. 2011
    AACR Selection Committee for Landon Foundation-AACR Innovator Award for Cancer Prevention Research
  30. 2011 - 2014
    Gastrointestinal Cancer Research Program, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  31. 2010 - 2020
    American Society of Clinical Oncology (ASCO) Program Committee
  32. 2010 - 2017
    International Digestive Cancer Alliance Advisory Board
  33. 2010 - 2015
    Threshold Pharmaceuticals, Consultant Drug Consultant
  34. 2010 - present
    AGA GI Oncology Committee for Prevention and Chemoprevention
  35. 2010
    EMD Serono, Scientific Advisory Board
  36. 2010 - present
    Mayo Clinic Center for Cell Signaling in Gastroenterology
  37. 2009 - 2010
    National Cancer Institute Translational Research Task Force, GI Steering Committee
  38. 2008 - 2012
    American Society of Clinical Oncology, Cancer Prevention Scientific Program Committee
  39. 2007 - 2010
    AGA, Research Awards Review Panel
  40. 2007 - 2010
    Research Awards Review Panel, American Gastroenterological Association
  41. 2007
    Specialized Programs of Research Excellence, National Cancer Institute, National Institutes of Health
  42. 2007 - present
    Scientific Advisory Committee, Mayo Clinic SPORE in Pancreatic Cancer, Mayo Clinic Cancer Center
  43. 2007 - present
    GI Executive Committee, North Central Cancer Treatment Group
  44. 2006 - 2010
    Research Committee, Division of Gastroenterology and Hepatology, Department of Medicine
  45. 2005 - 2012
    NCI-Supported Colon Cancer Family Registry, Biospecimen Committee
  46. 2005 - present
    Colorectal Neoplasia Group, Division of Gastroenterology and Hepatology, Department of Internal Medicine
  47. 2004 - 2006
    Scientific Advisory Board, Pfizer Pharmaceutical, Inc.
  48. 2004 - present
    GI Translational Research Committee, Mayo Clinic/North Central Cancer Treatment Group
  49. 2004 - present
    GI Subcommittee, North Central Cancer Treatment Group
  50. 2003 - present
    Mayo Clinic Division of Population Science
  51. 2003
    Cancer Epidemiology Study Section, National Institutes of Health
  52. 2002 - 2013
    North Central Cancer Treatment Group, GI Executive Committee
  53. 2002 - present
    Mayo Clinic Comprehensive Cancer Center
  54. 2001 - 2008
    NCI-Sponsored Phase III Trial, Data and Safety Monitoring Board
  55. 2001 - 2002
    Clinical Council Subcommittee on Clinical Research Funding, University of Texas M.D. Anderson Cancer Center
  56. 2001 - 2002
    Steering Committee, GI Multidisciplinary Program, University of Texas M.D. Anderson Cancer Center
  57. 2001 - 2002
    Steering Committee, Division of Cancer Prevention, University of Texas M.D. Anderson Cancer Center
  58. 2001 - 2002
    Colorectal Cancer Practice Guidelines, University of Texas M.D. Anderson Cancer Center
  59. 2001
    Data and Safety Monitoring Board, NCI-sponsored Phase III trial, University of California, Irvine
  60. 2001
    University of California, Irvine
  61. 2000 - 2001
    Medical Practice Subcommittee, University of Texas M.D. Anderson Cancer Center
  62. 2000
    Site Visit for PO1 Grant in Chemoprevention, National Institutes of Health
  63. 2000
    Site Visit for PO1 Grant in Chemoprevention, National Institutes of Health
  64. 2000
    Faculty Achievement Award Selection Committee, University of Texas M.D. Anderson Cancer Center
  65. 1999 - 2002
    Southwest Oncology Group, Cancer Control Research and Chemoprevention Committee
  66. 1999
    American Association for Cancer Research, Selection Committee for DeWitt S. Goodman Annual Lecture
  67. 1999 - 2002
    Clinical Research Committee, University of Texas M.D. Anderson Cancer Center
  68. 1999 - 2001
    Advisory Committee for Institutional Grants and Contracts Database, University of Texas M.D. Anderson Cancer Center
  69. 1999
    Selection Committee for DeWitt S. Goodman Annual Lecture, American Association for Cancer Research
  70. 1999
    Faculty Search Committee, Department of Pathology, University of Texas M.D. Anderson Cancer Center
  71. 1999 - present
    Southwest Oncology Group
  72. 1999 - present
    Cancer Control Research Committee, Southwest Oncology Group
  73. 1999 - present
    Chemoprevention Subcommittee, Cancer Control Research Committee, Southwest Oncology Group
  74. 1998 - present
    American College of Physicians
  75. 1997 - present
    American Gastroenterological Association, GI Oncology Committee
  76. 1997 - present
    GI Oncology Committee, American Gastroenterological Association
  77. 1997 - present
    American Society of Clinical Oncology
  78. 1995 - 2002
    University of Texas M.D. Anderson Cancer Center
  79. 1995 - present
    American Association for Cancer Research
  80. 1994 - 1998
    Crohn's and Colitis Foundation of America
  81. 1993 - 2002
    University of Texas M.D. Anderson Cancer Center
  82. 1993 - 1994
    Parenteral Nutrition Support committee, University of Texas M.D. Anderson Cancer Center
  83. 1991 - present
    American Gastroenterological Association
  84. 1988 - 1990
    American College of Physicians
  85. 1988 - present
    American College of Physicians
  86.  
    Medical Advisory Board, Houston Gulf Coast/So. Texas Chapter, Crohn's and Colitis Foundation of America

Publications

See my publications